Jacobson Pharma (HKSE:02633) Dividend Payout Ratio: 0.54 (As of Mar. 2026) — 35% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02633 Jacobson Pharma Corp Ltd HKSE:02633
56 GF Score
Price HK$1.04
GF Value HK$0.85
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Jacobson Pharma Dividend Payout Ratio?

Jacobson Pharma HKSE:02633 -0.96% 56 Dividend Payout Ratio is 0.54 as of Mar. 2026, which is 35% above its 10-year median of 0.40. GuruFocus rates HKSE:02633 with a GF Score™ of 56/100 and a GF Value™ of HK$0.85 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 446 Drug Manufacturers companies, Jacobson Pharma ranks worse than 74.89% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Jacobson Pharma's Dividend Payout Ratio for the months ended in Mar. 2026 was 0.54.

The historical rank and industry rank for Jacobson Pharma's Dividend Payout Ratio or its related term are showing as below:

HKSE:02633' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.07   Med: 0.4   Max: 0.65
Current: 0.65

During the past 13 years, the highest Dividend Payout Ratio of Jacobson Pharma was 0.65. The lowest was 0.07. And the median was 0.40.

HKSE:02633's Dividend Payout Ratio is ranked worse than
74.89% of 446 companies
in the Drug Manufacturers industry
Industry Median: 0.38 vs HKSE:02633: 0.65

As of today (2026-09-02), the Dividend Yield % of Jacobson Pharma is 9.33%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Jacobson Pharma was 10.05%. The lowest was 0.60%. And the median was 5.33%.

Jacobson Pharma's Dividends per Share for the months ended in Mar. 2026 was HK$0.04.

During the past 12 months, Jacobson Pharma's average Dividends Per Share Growth Rate was 50.80% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 21.20% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 25.60% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Jacobson Pharma was 84.20% per year. The lowest was -15.00% per year. And the median was 14.10% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Jacobson Pharma (HKSE:02633) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Jacobson Pharma Dividend Payout Ratio Related Terms

Jacobson Pharma Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Jacobson Pharma's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jacobson Pharma Dividend Payout Ratio Chart

Jacobson Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.30 0.50 0.45 0.43 0.65

Jacobson Pharma Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.42 0.42 0.43 0.78 0.54

HKSE:02633 vs ZTS: Dividend Payout Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Jacobson Pharma's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jacobson Pharma Dividend Payout Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jacobson Pharma's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Jacobson Pharma's Dividend Payout Ratio falls into.


HKSE:02633
56GF Score
Jacobson Pharma Corp Ltd HKSE:02633
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jacobson Pharma Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Jacobson Pharma's Dividend Payout Ratio for the fiscal year that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Mar. 2026 )/ EPS without NRI (A: Mar. 2026 )
=0.098/ 0.151
=0.65

Jacobson Pharma's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2026 )/ EPS without NRI (Q: Mar. 2026 )
=0.043/ 0.08
=0.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 0.54 mean?
Jacobson Pharma (HKSE:02633) has a Dividend Payout Ratio of 0.54 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Jacobson Pharma and its competitors. This is 35% above median its historical median of 0.40. Over the past decade, Jacobson Pharma's Dividend Payout Ratio has ranged from 0.07 to 0.65. According to the industry distribution chart, Jacobson Pharma ranks #334 out of 446 companies in the Drug Manufacturers industry, placing it in the top 74.9%.
Is Jacobson Pharma's Dividend Payout Ratio too high?
Jacobson Pharma's current Dividend Payout Ratio of 0.54 is 35% above median its 10-year median of 0.40. Over the past 10 years, this metric has ranged from a low of 0.07 to a high of 0.65. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. Jacobson Pharma's value of 0.54 is 42.1% above this industry median. Based on the distribution chart, Jacobson Pharma ranks #334 out of 446 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Jacobson Pharma has a GF Score™ of 56/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jacobson Pharma's Dividend Payout Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Jacobson Pharma ranks #334 out of 446 companies for Dividend Payout Ratio. This places Jacobson Pharma in the lower half of its industry. The industry median Dividend Payout Ratio is 0.38. Jacobson Pharma's value of 0.54 is 42.1% above this benchmark. Historically, Jacobson Pharma's own Dividend Payout Ratio has ranged from 0.07 to 0.65 over the past decade. While the company's 10-year median is 0.40 vs. the industry median of 0.38, Jacobson Pharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 446 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jacobson Pharma's current Dividend Payout Ratio of 0.54 is 42.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Jacobson Pharma and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jacobson Pharma's current Dividend Payout Ratio is 0.54, which is 35% above median its own 10-year median of 0.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jacobson Pharma stock overvalued right now?
Based on GuruFocus' analysis, Jacobson Pharma (HKSE:02633) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$0.85, compared to a current price of HK$1.04 — trading 21.8% above its estimated fair value. The current Dividend Payout Ratio is 0.54, which is 35% above median its 10-year median of 0.40 and 42.1% above the Drug Manufacturers industry median of 0.38. Jacobson Pharma's overall GF Score™ is 56/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Jacobson Pharma (HKSE:02633), the current Dividend Payout Ratio is 0.54 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jacobson Pharma (HKSE:02633) Overvalued in 2026?

Based on GuruFocus' analysis, Jacobson Pharma stock appears to be overvalued. The current stock price of HK$1.04 is trading 21.8% above its estimated GF Value™ of HK$0.85. GuruFocus considers Jacobson Pharma to be Modestly Overvalued.

Key valuation signals for HKSE:02633:

  • Dividend Payout Ratio: 0.54 (35% above median its 10-year median of 0.40)
  • GF Value™: HK$0.85 vs. price of HK$1.04 (21.8% above fair value)
  • GF Score™: 56/100 with 2 warning signs
  • Industry Position: 42.1% above the Drug Manufacturers median (#334 of 446)

No single metric tells the full story. See the HKSE:02633 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jacobson Pharma Business Description

Address 388 Kwun Tong Road, Unit 2313-18, 23rd Floor, Tower 1, Millennium City 1, Kwun Tong, Kowloon, Hong Kong, HKG
Jacobson Pharma Corp Ltd is an investment holding company. It is principally engaged in the development, production, marketing, and sale of generic drugs. The company's operating segment includes Generic drugs; Branded healthcare, Wholesale, and retail The generic drugs segment develops, manufactures, and distributes a host of off-patent medicines for various therapeutic use. It generates maximum revenue from the Generic drugs segment. Geographically, it derives a majority of its revenue from Hong Kong and also has a presence in Mainland China, Macau, Singapore, and Other Countries.
56GF Score

Get the complete analysis for HKSE:02633

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$1.04
Price
HK$0.85
GF Value